Low dead space syringes reduce HCV incidence among people who inject drugs

The use of low dead space syringes was associated with a 76% reduction in the odds of hepatitis C virus infection among people who inject drugs, according to a study of U.K. data.
This study was prompted by the WHO recommending that needle exchange programs offer low dead space syringes (LDSSs) in a bid to reduce [the] incidence of bloodborne viruses,” Adam J. W. Trickey, MSc, BSc, a research fellow at the Bristol Medical School in England, told Healio. “However, there was previously no real-world evidence of these syringes reducing incidence of bloodborne viruses.”
Trickey

The use of low dead space syringes was associated with a 76% reduction in the odds of hepatitis C virus infection among people who inject drugs, according to a study of U.K. data.
This study was prompted by the WHO recommending that needle exchange programs offer low dead space syringes (LDSSs) in a bid to reduce [the] incidence of bloodborne viruses,” Adam J. W. Trickey, MSc, BSc, a research fellow at the Bristol Medical School in England, told Healio. “However, there was previously no real-world evidence of these syringes reducing incidence of bloodborne viruses.”
Trickey